Key statistics
On Friday, Precigen Inc (PGEN:NSQ) closed at 3.32, -39.25% below its 52-week high of 5.47, set on Feb 17, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.26 |
|---|---|
| High | 3.34 |
| Low | 3.22 |
| Bid | 3.30 |
| Offer | 3.36 |
| Previous close | 3.37 |
| Average volume | 5.41m |
|---|---|
| Shares outstanding | 353.82m |
| Free float | 305.38m |
| P/E (TTM) | -- |
| Market cap | 1.19bn USD |
| EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Mar 06 2026 21:00 GMT.
More ▼
- New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
- Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
- Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
